Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Scheinberg

Showing results (141-150 of 162) with videos related to

Pageof 17
Sort By:
Science Translational Medicine|March 15, 2013
Targeting the intracellular WT1 oncogene product with a therapeutic human antibodyTao Dao, Su Yan, Nicholas Veomett, et al.
Nature Biotechnology|September 22, 2015
Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1Tao Dao, Dmitry Pankov, Andrew Scott, et al.
Nature Chemical Biology|December 31, 2021
Engineering CAR-T cells to activate small-molecule drugs in situThomas J Gardner, J Peter Lee, Christopher M Bourne, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 5, 2020
A Genomic Profile of Local Immunity in the Melanoma Microenvironment Following Treatment with α Particle-Emitting Ultrasmall Silica NanoparticlesAleksandra M Urbanska, Raya Khanin, Simone Alidori, et al.
Blood|December 4, 2023
A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AMLTao Dao, Guangyan Xiong, Sung Soo Mun, et al.
Science (New York, N.Y.)|July 24, 2025
Design of high-specificity binders for peptide-MHC-I complexesBingxu Liu, Nathan F Greenwood, Julia E Bonzanini, et al.
Blood|April 15, 2022
A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignanciesMartin G Klatt, Tao Dao, Zhiyuan Yang, et al.
Blood Advances|February 2, 2018
Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemiaPeter G Maslak, Tao Dao, Yvette Bernal, et al.
Nature Communications|July 30, 2016
Deconvoluting hepatic processing of carbon nanotubesSimone Alidori, Robert L Bowman, Dmitry Yarilin, et al.
Bioconjugate Chemistry|April 5, 2021
Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy ApplicationsMegan M Dacek, Darren R Veach, Sarah M Cheal, et al.
Pageof 17

Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
Science Translational Medicine|March 15, 2013
Targeting the intracellular WT1 oncogene product with a therapeutic human antibodyTao Dao, Su Yan, Nicholas Veomett, et al.
Nature Biotechnology|September 22, 2015
Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1Tao Dao, Dmitry Pankov, Andrew Scott, et al.
Nature Chemical Biology|December 31, 2021
Engineering CAR-T cells to activate small-molecule drugs in situThomas J Gardner, J Peter Lee, Christopher M Bourne, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 5, 2020
A Genomic Profile of Local Immunity in the Melanoma Microenvironment Following Treatment with α Particle-Emitting Ultrasmall Silica NanoparticlesAleksandra M Urbanska, Raya Khanin, Simone Alidori, et al.
Blood|December 4, 2023
A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AMLTao Dao, Guangyan Xiong, Sung Soo Mun, et al.
Science (New York, N.Y.)|July 24, 2025
Design of high-specificity binders for peptide-MHC-I complexesBingxu Liu, Nathan F Greenwood, Julia E Bonzanini, et al.
Blood|April 15, 2022
A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignanciesMartin G Klatt, Tao Dao, Zhiyuan Yang, et al.
Blood Advances|February 2, 2018
Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemiaPeter G Maslak, Tao Dao, Yvette Bernal, et al.
Nature Communications|July 30, 2016
Deconvoluting hepatic processing of carbon nanotubesSimone Alidori, Robert L Bowman, Dmitry Yarilin, et al.
Bioconjugate Chemistry|April 5, 2021
Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy ApplicationsMegan M Dacek, Darren R Veach, Sarah M Cheal, et al.
Pageof 17